NewYou can listen to Fox News articles now!
The Trump administration says it’s interested in exploring psychedelic drugs as they may be in the treatment of PTSD and other frustrating situations Mental health issuesvarious officials shared it.
A spokesperson for the U.S. Department of Health and Human Services (HHS), shared the goal of ensuring that all Americans, especially U.S. veterans, can provide safe and effective treatments for conditions such as PTSD, addiction, and depression. Robert J. Kennedy Jr. said in a statement to Fox News Digital.
Secretary Kennedy is committed to applying rigorous evidence-based science to research efforts designed to address these serious Health Challenge. ”
FDA approves the first AI tool to predict breast cancer risk
In recent years, researchers have been actively studying the potential of psychedelic drugs such as MDMA and psilocybin (“”Magic Mushroom”) Treatment of mental health disorders.
The U.S. Food and Drug Administration (FDA) does not approve MDMA for clinical use, but can be studied in a clinical setting.
Psychedelic research has been supported by the Trump administration in treating PTSD and mental health conditions. (iStock)
psilocybin is listed as a Schedule I substance under the Controlled Substances Act, meaning it has “high potential for abuse, (not) currently accepted for medical use in the United States, and (() lacks the safety and safety of use under medical supervision”.
However, in Oregon, Colorado, and New Mexico, psilocybin adjuvant therapy is legal.
“Show Commitment”
Dr. Luke Twelves, vice president of medical medicine at Lindas Healthcare in London, said psychedelic drugs “show real hope.”
Clinical trials find this treatment safe and effective for patients who are struggling severely Mental Health Question, according to twelve.
Studies show that common supplements and medications can cause liver damage
“Taking psilocybin as an example, this proves the excellent effect of severe depression, which does not respond to other drugs,” he told Fox News Digital Digital. “MDMA also showed a similar breakthrough PTSD treatment. ”
Clinical trials also investigate how psychedelic drugs can help end-of-life anxiety, addiction, Eating disordersHe added, chronic pain and obsessive-compulsive disorder.
In recent years, researchers have been actively investigating the potential of psychedelic drugs, such as MDMA and psilocybin for the treatment of mental health disorders. (iStock)
Twelves said the researchers face challenges in regulatory barriers and proper placebo control.
“Given that these treatments can change the lives of people suffering from other diseases that have no other effective effects, it is crucial that we have to do this study correctly,” he said. “The aim is to bring safe, proven psychedelic therapy to patients who need them the most.”
Veterans’ Potential
At the May 1 Cabinet Meeting of President Trump Veterans Affairs “We are opening up the possibility of psychedelic therapy,” said Secretary Doug Collins.
retire Sergeant Sergeant Jonathan Lubecki recently told Fox News’ Alexandria Hoff that MDMA stopped PTSD while participating in clinical trials.
VA is now opening up psychedelic therapy to promote the possibility of veterans’ health. (iStock)
He said: “(i) took my first MDMA.
Veterans Affairs Press Secretary Peter Kasperowicz told Fox News Digital that the department is safely exploring all pathways to promote veterans’ health.
Fallujah Vet turns the Medal of Heroism into a rehabilitation mission with the service dog program
“Preliminary findings have yielded positive results for psychedelic adjuvant therapy for treating mental health conditions,” he said.
VA is currently running 11 Clinical trials A total of about 800 veterans will participate at all stages.
Click here to get the Fox News app
“The purpose of these trials is to determine whether compounds such as MDMA and psilocybin can treat veterans with post-traumatic stress disorder, drug-resistant depression, severe depression, and potentially other mental health Health status,” said Casperovic.
psilocybin is a Plan I drug under the Controlled Substances Act, but psilocybin adjuvant treatment is legal in Oregon, Colorado and New Mexico. (iStock)
A MDMA study published in the American Journal of Psychiatry published in January 2025 found that the substance is different from classical psychedelic drugs.
“MDMA allows individuals to maintain complete self-function and greater extent Cognition and perceived clarity while still experiencing prosocial change in consciousness states, promote profound breakthroughs in emotional therapy. ”
Click here to sign up for our health newsletter
The researchers concluded that MDMA exhibits an improvement in the level of “trust, empathy, self-compassion and” tolerance that traditional psychotherapy lacks.
VA currently has 11 psychedelic clinical trials at all stages. (iStock)
“It’s time to resolve the mental health crisis,” Doug Drysdale, CEO of Canadian pharmaceutical company Cybin, told Fox News Digital.
He said government officials value the potential benefits of alternative mental health treatments, which are “satisfactory”.
“It’s time to resolve the mental health crisis.”
Cybin is currently in Phase 3 of the CYB003 study, a psilocybin awarded a breakthrough therapy by the FDA. Major Depression (MDD).
“In the Phase 2 MDD study completed by Cybin, the long-term efficacy results showed that 71% of participants were relieved due to depression, while 100% responded to treatment 12 months after just two doses of 16 mg Cyb003.”
Risks and warnings
Dr. Marc Siegel, PhD, Professor of Clinical Medicine NYU Langone Medical Center Senior medical analysts at Fox News have previously interviewed two psychedelic psychogenic researchers in the country – Dr. Rachel Yehuda, founder and director of the Center for Psychological Psychological Therapy and Trauma Research in Mount Sinai, New York, and Dr. Charles Marmar, director of the PTSD research program at Nyu Langone.
“There are huge drawbacks in terms of unregulated leisure uses.”
Siegel told Fox News Digital at the time that they agreed that if very rigorous medical guidance research was conducted under very strict medical guidance, there were huge drawbacks in unregulated recreational uses and that they would have therapeutic potential. ”
Experts emphasize the importance of managing psychedelic drugs in a safe environment when treating mental health conditions. (iStock)
“If managed carefully Medical experts,” Siegel added.
Ryan Moss, chief scientific officer of Filamment Health, a Canadian clinical-stage natural psychedelic drug development company, stressed that it is important to manage psychedelic drugs in a safe environment when treating mental health conditions.
For more health articles, please visit www.foxnews.com/health
“Psychedelic experiences are sometimes characterized by anxiety, hallucinations and paranoia,” Moss previously told Fox News Numbers. “Some patients using traditional psychedelic drugs reported Cardiovascular events In clinical trials. ”
To mitigate these risks, MOSS recommends that clinical trial participants receive thorough preparation and monitoring by trained professionals during the session.
Melissa Rudy and Angelica Stabile of Fox News Digital contributed the coverage.
